Today's News |
|
Vancouver-Based AbCellera to Raise US $200-Million in Nasdaq Public Listing
Tuesday, November 24, 2020
Vancouver, BC, November 24, 2020--Vancouver-based biotech developer AbCellera Biologics Inc, which has partnered with Eli Lilly for its COVID-19 antibody drug, on Friday filed for a $200 million initial public offering on the Nasdaq. The listing plan from the Canadian firm comes at a time of strong demand for new biotechnology stocks. Reuters reported in September that AbCellera had hired investment banks for a U.S. IPO and could look to raise between $200 million and $300 million.
|
Share |
|||
|
Member Toolbar |
Financial Post Posted: Nov 24, 2020 |
News Actions |
Navigation |
Hiring Today |
|||||||||||||||||||
See All Jobs |
|||||||||||||||||||
Copyright © T-NET. All Rights Reserved. | https://www.bctechnology.com |
|